conv.

← The whole story
Health
Roche's obesity drug shows 15.5% weight loss in mid-stage diabetes trial

Roche announces diabetes trial results: 15.5% weight loss, improved blood sugar control

1 Sep 22 1:32 AM · 1d ago · 2 articles · 1 source · development 1 of 2

Roche reported that enicepatide achieved 15.5% average body weight loss and met primary endpoints for blood sugar control in a 447-patient mid-stage trial. About 62% of patients achieved non-diabetic HbA1c levels, with side effects mostly mild to moderate.

Roche announces diabetes trial results: 15.5% weight loss, improved blood sugar control
Investing.com News

Roche Swiss pharmaceutical companyEli LillyEli Lilly Obesity drug market leaderNovo Nordisk Obesity drug market leaderAstraZeneca Competing obesity drug developerAmgen Competing obesity drug developer

The whole story articles the bright band is this development · numbered dots are the others · click one to jump

Peak 2 pieces in one hour at Sep 22, 1 AM; 4 pieces over 2 days (4 articles) Sep 22, 1 AM — 2 pieces · 2 articles — Google News 2Sep 22, 2 AM — quietSep 22, 3 AM — quietSep 22, 4 AM — quietSep 22, 5 AM — quietSep 22, 6 AM — 1 piece · 1 article — Newswires 1Sep 22, 7 AM — 1 piece · 1 article — Newswires 1Sep 22, 8 AM — quietSep 22, 9 AM — quietSep 22, 10 AM — quietSep 22, 11 AM — quietSep 22, 12 PM — quietSep 22, 1 PM — quietSep 22, 2 PM — quietSep 22, 3 PM — quietSep 22, 4 PM — quietSep 22, 5 PM — quietSep 22, 6 PM — quietSep 22, 7 PM — quietSep 22, 8 PM — quietSep 22, 9 PM — quietSep 22, 10 PM — quietSep 22, 11 PM — quietYesterday, 12 AM — quietYesterday, 1 AM — quietYesterday, 2 AM — quietYesterday, 3 AM — quietYesterday, 4 AM — quietYesterday, 5 AM — quietYesterday, 6 AM — quietYesterday, 7 AM — quietYesterday, 8 AM — quietYesterday, 9 AM — quietYesterday, 10 AM — quietYesterday, 11 AM — quietYesterday, 12 PM — quietYesterday, 1 PM — quietYesterday, 2 PM — quietYesterday, 3 PM — quietYesterday, 4 PM — quietYesterday, 5 PM — quietYesterday, 6 PM — quietYesterday, 7 PM — quietYesterday, 8 PM — quietYesterday, 9 PM — quietYesterday, 10 PM — quietYesterday, 11 PM — quietToday, 12 AM — quiet 12
1Roche announces diabetes trial results…2Roche plans late-stage trials for 2027
8 AM4 PMyesterday8 AM4 PMnow · 1:00 AM ET

What was reported 2 claims about this development

  1. 2 outlets Roche GLP-1 delivers 16% weight loss in mid-stage trial

    first by Seeking Alpha, 1d ago · also Investing.com News

    1 more headline
  2. 2 outlets Roche Obesity Shot Cuts Body Weight 15.5% in Mid-Stage Trial

    first by Bloomberg.com, 1d ago · also Reuters

    1 more headline

All 2 developments of Roche's obesity drug shows 15.5% weight loss in mid-stage… →

NewswiresGoogle News